PATENT CLAIM ANALYSIS

Application Number: 15922240
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "230200"]

Abstract:
The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC

Claim (Index 4):
The combination according to  claim 1 , further comprising lamivudine or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 90.0
- Lexical Diversity: 1.40625
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15366442', '15533068', '15847971', '15300405', '15231365']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7489745005885949
- 35 USC 102 Novelty (BERT): 0.5259807075436392
- Combined Prediction Score: 0.7266751212840994
- Mean Citation Score: 258.70806200000004
- Max Citation Score: 340.2566
- Similarity Product: 245.6863177204609

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test